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Regulatory T Cells from IL-10-Deficient Mice Fail
to Suppress Contact Hypersensitivity Reactions Due
to Lack of Adenosine Production
Sabine Ring1, Alexander H. Enk1 and Karsten Mahnke1
CD4þCD25þFoxp3þ regulatory T cells (Tregs) produce immunosuppressive adenosine by degradation of
adenosine triphosphate (ATP) by the ectonucleotidases CD39 and CD73. In this sequence of events, ATP is not
only the substrate for generation of adenosine but it also activates the immunosuppressive functions of Tregs.
To compare the effects of ATP on IL-10-deficient (IL-10/) Tregs with wild-type (wt) Tregs, we incubated both
types of Tregs with ATP and assessed their phenotype and function. We show that IL-10/ Tregs failed to
become activated by ATP and were impaired in adenosine production. As a consequence, IL-10/ Tregs were
unable to block adherence of effector T cells to the endothelium in vitro. When testing the signaling of the ATP
receptor P2X7 in IL-10
/ Tregs, we recorded no elevation of intracellular calcium after engagement of P2X7
receptors, as compared with wt Tregs, thus indicating that IL-10/ Tregs fail to react normally to ATP and display
impaired adenosine production, which explains their inability to suppress contact hypersensitivity responses.
Therefore, when using IL-10/ Tregs in different disease models, one has to take into account that adenosine
production is abrogated and reduced suppressive effects may not be exclusively attributable to the lack of
IL-10 production.
Journal of Investigative Dermatology (2011) 131, 1494–1502; doi:10.1038/jid.2011.50; published online 24 March 2011
INTRODUCTION
Regulatory T cells (Tregs) are characterized by their
suppressive capacity exerted by surface molecules and/or
soluble factors (Vignali et al., 2008). Among the recently
discovered suppressive means, we along with others have
identified the production of adenosine as a mechanism,
which to our knowledge is previously unreported, by which
Tregs suppress T-cell proliferation in vitro and immune
reactions in vivo (Borsellino et al., 2007; Deaglio et al., 2007;
Ring et al., 2009).
Tregs generate adenosine by degradation of adenosine
triphosphate (ATP) through the ectonucleotidases CD39 and
CD73. CD39 catalyzes the initial degrading step by convert-
ing ATP to adenosine diphosphate, and subsequently,
adenosine is produced by CD73. Adenosine can then
act as a suppressor of leukocyte activation, which has
been demonstrated in humans and mice (Huang et al.,
1997; Lappas et al., 2005; Odashima et al., 2005; Sitkovsky
et al., 2008).
In addition to serving as a substrate for adenosine
generation by Tregs, ATP can also act as a proinflammatory
signal, which was demonstrated by its capacity to activate the
inflammasome (Di Virgilio, 2007). However, ATP can also
have anti-inflammatory properties, as it directly activates
Tregs. Exposure of Tregs to ATP results in drastically
increased suppressive activity of Tregs in vitro, and we
have shown that blockage of ATP receptors on Tregs
abrogated their suppressive capacity in contact hypersensi-
tivity (CHS) reactions in vivo (Ring et al., 2010). Thus, these
data underline the importance of ATP in Treg activation
and function.
In addition to adenosine, another soluble factor, namely
IL-10 is frequently attributed to the suppressive function of
Tregs, because IL-10-deficient (IL-10/) Tregs fail to suppress
colitis and experimental autoimmune encephalomyelitis
(Asseman et al., 1999; Zhang et al., 2004). Similarly, in
CHS reactions, IL-10/ Tregs were unable to suppress the
inflammatory response, but interestingly, the injection of
recombinant IL-10 did not re-establish the suppressive effects
of IL-10/ Tregs (Ring et al., 2006). Thus, these data indicate
that the lacking production of IL-10 may not be the only
cause for the absent suppressive activity of IL-10/ Tregs.
Therefore, we investigated the activation and generation of a
second soluble suppressor adenosine in wild-type (wt) and IL-
10/ mice. We found that Tregs isolated from IL-10/ mice
do not become activated by ATP and produce significantly
reduced amounts of adenosine. As a consequence, IL-10/
Tregs failed to suppress the adherence of effector T cells on
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endothelial cells. Thus, when using IL-10/ Tregs in several
disease models, one has to take into account that production
of adenosine is severely reduced, and that therefore reduced
suppressive effects of IL-10/ Tregs may not be attributable
to the missing IL-10 production. Instead contribution of the
altered adenosine production may have a substantial impact
on suppression.
RESULTS
Tregs from IL-10/ mice are insensitive to ATP-mediated
activation
In recent studies, we have demonstrated that exposure of
Tregs to ATP in a micromolar range leads to activation and
development of the full arsenal of inhibitory mechanisms of
Tregs in vitro and in vivo, which is one prerequisite for
conveying their suppressive function in CHS reactions (Ring
et al., 2010). In addition, IL-10/ Tregs failed to suppress the
elicitation phase of CHS reactions, and this lack of function
was not exclusively due to the loss of IL-10 production, as
injection of recombinant IL-10 did not reconstitute the
suppressive effects of IL-10/ Tregs (Ring et al., 2006).
Therefore, we asked whether ATP fails to activate IL-10/
Tregs, which would explain their inability to suppress CHS
responses independent of the absent IL-10 production.
We first analyzed whether naive IL-10/ Tregs become
activated in vivo after hapten application when injected into
sensitized mice, as previously shown by us for wt Tregs
(Ring et al., 2010). Figure 1a and Supplementary Figure S1a
online show that 24 hours after challenge, IL-10/ Tregs
did not upregulate the characteristic activation markers
CD69 and CD44, and also that CD62L, which decreases
during activation, remained unchanged. In contrast, wt
Tregs become strongly activated in the blood 24 hours after
challenge (Figure 1a). Thus, IL-10/ Tregs remained in a
naive status. As the activation of Tregs during CHS reactions
depends on the amount of extracellular ATP (Ring et al.,
2010), we next investigated the effect of ATP on IL-10/
Tregs in vitro. Here, IL-10/ Tregs were insensitive to
externally added ATP and remained in a naive state (Figure
1b and Supplementary Figure S1b and c online). In contrast,
wt Tregs became activated by ATP in a dose-dependent
manner. Nevertheless, stimulation of the T-cell receptor using
anti-CD3/anti-CD28 antibodies demonstrated that IL-10/
Tregs can indeed be activated by adequate stimuli, indicating
that cells do not harbor a general failure in activation. Thus,
we conclude that IL-10/ Tregs are specifically impaired in
their ability to become activated by ATP.
It is known that activation of Tregs is necessary to induce
the full arsenal of inhibitory means, and we have shown that
production of adenosine in particular is largely upregulated
by ATP-activated Tregs. Therefore, we compared the ability
of IL-10/ Tregs with that of wt Tregs to produce adenosine
in response to ATP stimulation. We detected that production
of adenosine was significantly reduced in IL-10/ Tregs than
in wt Tregs (Figure 2a). Remarkably, activation of IL-10/
Tregs with anti-CD3/anti-CD28 restores their ability to
degrade ATP into adenosine, indicating that IL-10/ Tregs
do not harbor a generalized defect in adenosine production.
Moreover, the suppressive capacity of IL-10/ Tregs
preincubated with ATP on the proliferation of effector T cells
was strongly reduced (Figure 2b), and the inhibitory action of
IL-10/ Tregs on adherence of effector T cells to endothelial
cells, which is mediated by adenosine, was abrogated (Figure
2c). To further rule out that the absence of IL-10 solely
accounts for these effects, we added rmIL-10 in the flow
chamber experiments. Here, we show that substitution of IL-
10 alone was not sufficient to prevent the adherence of T cells
to endothelial cells in the in vitro flow chamber (Figure 2c).
Thus, these data show that it is not the lack of IL-10
production that causes the failure of IL-10/ Tregs to
suppress the interaction between T cells and endothelial
cells. Instead these data indicate that IL-10/ Tregs are
insensitive to ATP-mediated activation, resulting in a reduced
production of adenosine as compared with wt Tregs. As a
functional consequence, the suppressive capacity of IL-10/
Tregs is severely impaired.
The purinergic receptor P2X7 is required for ATP-mediated
activation of Tregs
To further delineate ATP-induced effects in Tregs, we set out
to analyze the respective ATP receptors involved in signaling.
Lymphocytes recognize extracellular ATP mainly by the
purinergic receptor P2X7. Thus, blocking of P2X7 on wt Tregs
with the highly selective antagonist KN-62 prevented ATP-
mediated upregulation of the activation markers CD69 and
CD44 in a concentration-dependent manner (Figure 3a).
Similarly, shedding of CD62L, which was described pre-
viously (Scheuplein et al., 2009) was inhibited by KN-62
(Supplementary Figure S2a online). In contrast, Tregs
incubated with ATP and the P2X1 antagonist NF-449 were
not defective in becoming activated by ATP (Supplementary
Figure S2b online), demonstrating the specific involvement of
the P2X7 receptor in mediating the recorded effects in Tregs.
As activation of the P2X7 receptor results in opening of ion
channels permeable to Ca2þ , Naþ , and Kþ ions, we further
analyzed the Ca2þ influx into Tregs after addition of ATP
with or without the P2X7 antagonist KN-62. Figure 3b and
Supplementary Figure S2c online show that ATP-induced
Ca2þ influx into Tregs is P2X7 dependent. The relevance of
this ATP signaling for Treg function could further be demons-
trated in suppression assays, showing that the suppressive
function of Tregs exposed to ATP was abrogated after appli-
cation of the P2X7 receptor antagonist KN-62 (Figure 3c).
Thus, the purinergic receptor P2X7 on Tregs is essential for
ATP-induced activation and consequently for exciting their
suppressive functions.
IL-10/ Tregs are impaired in Ca2þ -mediated intracellular
signaling
As our data indicate that IL-10/ Tregs do not become
activated by ATP, which normally triggers P2X7 receptors, we
hypothesized that the insensitivity of IL-10/ Tregs to ATP-
mediated activation could be due to a depressed expression
of P2X7 receptors. However, when analyzing the expression
of P2X7 receptors by flow cytometry, we did not detect any
substantial differences in wt Tregs and in IL-10/ Tregs
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Figure 1. IL-10/ Tregs are insensitive to ATP-mediated activation in vivo and in vitro. (a) Isolated IL-10/ or wt Tregs were labeled with PKH-PE,
analyzed by flow cytometry, and injected into sensitized mice. Twenty-four hours after challenge, Tregs were analyzed in different organs. Dot plots show
the expression of CD69, CD62L, and CD44 on freshly isolated and re-isolated Tregs. One representative experiment out of three is shown. (b) IL-10/ and
wt Tregs were stimulated with anti-CD3/anti-CD28, ATP, or left untreated. CD69 and CD44 were analyzed after 24 hours of culture. Dot plots show the
expression of the respective markers, and numbers given in each dot plot indicate the percentages of CD69þ Tregs or the MFI of CD44 on Tregs. One
representative experiment out of four is shown. ATP, adenosine triphosphate; LN, lymph node; MFI, mean fluorescence intensity; PKH-PE, PKH-phycoerythrin;
Treg, regulatory T cell; Unstim., unstimulated; wt, wild type.
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(Figure 4a), and these equal amounts of P2X7 receptors on the
surface of Tregs persisted even after activation of cells by TCR
stimulation (Supplementary Figure S3a online). Therefore,
we concluded that the abrogated activation of IL-10/ Tregs
is not due to reduced numbers of P2X7 receptors expressed
on their surface.
As the production of adenosine by IL-10/ Tregs was
greatly reduced (Figure 2a), we next analyzed the expression
of the ectonucleotidases CD39 and CD73, which are the
main sources for generation of adenosine by Tregs. Figure 4b
and Supplementary Figure S3b online show that the expres-
sion of CD39 and CD73 by IL-10/ Tregs was not changed
when compared with wt Tregs. Therefore, similar to results
obtained with the P2X7 receptor, the differential expression of
CD39 or CD73 is not responsible for the reduced adenosine
production recorded in IL-10/ Tregs. As the production of
adenosine nevertheless was abrogated in IL-10/ Tregs,
despite the normal expression of CD39 and CD73, we
conclude that failure of IL-10/ Tregs to become activated
by ATP also prevents stimulation of the catalytic activity of
the ectonucleotidases.
In light of these results, we further hypothesized that
signaling of ATP receptors may be altered in IL-10/ Tregs.
As we have demonstrated that engagement of P2X7 receptors
by ATP results in a Ca2þ influx into cells, we next analyzed
the increase in intracellular Ca2þ in IL-10/ Tregs in
response to ATP. In Figure 4c and Supplementary Figure S4
online, we show significantly reduced Ca2þ fluxes in IL-10/
Tregs stimulated with ATP as compared with wt Tregs.
However, Ca2þ influx after treatment with PMA (phorbol
12-myristate 13-acetate)/ionomycin was comparable in both
cell populations, indicating that IL-10/ Tregs do not suffer
from a generalized defect in Ca2þ -mediated signaling.
Therefore, we conclude that in IL-10/ Tregs, ATP-induced
elevation of intracellular calcium levels is impaired, which
may affect the activation of Ca2þ -mediated signaling further
downstream.
Extracellular IL-10 does not compensate for the lack of
intracellular IL-10 in IL-10/ Tregs
We next tested whether addition of extracellular rmIL-10
to cultures of IL-10/ Tregs with ATP restores the ability of
IL-10/ Tregs to respond to ATP signals. Analyzing the
surface expression of activation markers and determining
adenosine production in the supernatants of Treg cultures
demonstrated no influence of rmIL-10 on IL-10/ Tregs
(Figure 5a and c). These data are consistent with our results
obtained in the flow chamber (Figure 2c), showing that
addition of rmIL-10 to IL-10/ Tregs was not sufficient to
restore their suppressive capacity. Analysis of the expression
of IL-10 receptors on IL-10/ Tregs in comparison with wt
Tregs revealed that both cell types express equal amounts of
the receptor (data not shown), indicating that the unrespon-
siveness of IL-10/ Tregs to rmIL-10 is not due to differential
expression of the IL-10 receptor in the respective Tregs.
Vice versa, we could show that neutralization of extra-
cellular IL-10 with anti-IL-10 in cultures of wt Tregs did not
result in an unresponsiveness of wt Tregs to stimulation
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Figure 2. Reduced production of adenosine by IL-10/ Tregs. (a) Wt and IL-10/ Tregs were differently stimulated for 24 hours; supernatants were
analyzed for adenosine using HPLC. The graph shows the mean adenosine production of Treg±SD of four independent experiments (*Po0.001).
(b) CD4þCD25 T cells and Tregs were stimulated separately for 24 hours. Cells were washed, and CD4þCD25 T cells were co-cultured with differently
pretreated wt Tregs in the stated ratios. Data show the mean proliferation of CD4þCD25 T cells±SD of four independent experiments (*Po0.001).
(c) Endothelial cells were differently treated and superfused with effector T cells. The merged pictures of flowing CD4þCD25 T cells after 59minutes
(red) and after 60minutes (green) of flow are shown. Non-moving, adherent cells appear yellow. Bar¼50 mm. ATP, adenosine triphosphate;
HPLC, high-pressure liquid chromatograph; TNFa, tumor necrosis factor-a; Treg, regulatory T cell; wt, wild type.
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by ATP (Figure 5b and d). Therefore, we conclude that
the insensitivity of IL-10/ Tregs to activation by ATP
(and consequently the reduced production of adenosine) is
neither due to the amount of extracellular IL-10 nor caused
by differential IL-10 receptor expression. Instead it is
conceivable that differences in intracellular signaling trans-
duced by P2X7 receptors may account for the reduced
activation/suppression of IL-10/ Tregs.
DISCUSSION
Here, we have shown that IL-10/ Tregs are severely
impaired in their activation by ATP and production of
adenosine as compared with wt Tregs. These results are
particularly important as IL-10/ Tregs are frequently used in
experimental settings to determine the relative contribution of
IL-10 production to suppression by Tregs.
The pleiotropic suppressive effects of IL-10 in general are
well known, and its production by Tregs seems to be crucial
for suppression of colitis, experimental autoimmune ence-
phalomyelitis, and also during tumor growth (Asseman et al.,
1999; Zhang et al., 2004; Nishikawa and Sakaguchi, 2010).
So far, IL-10 has been believed to be a major soluble
suppressive factor produced by Tregs. However, more
recently, we along with others have established that
extracellularly generated adenosine also conveys suppressive
effects (Borsellino et al., 2007; Deaglio et al., 2007; Sitkovsky
et al., 2008; Ring et al., 2009). For example, in CHS
reactions, it suppresses the upregulation of E- and P-selectin
and thus blocks inflammatory reactions (Ring et al., 2009).
Moreover, in tumor environments, Treg-derived adenosine
may be a key component that impedes anti-tumor immunity
(Ohta et al., 2006; Pellegatti et al., 2008; Di Virgilio et al.,
2009a). Thus, at least two different mechanisms of
Treg-mediated suppression by soluble factors exist: IL-10
release and adenosine production.
So far, Tregs from IL-10/ mice were frequently used to
verify the relative contribution of Treg-derived IL-10 in
suppression in various experimental settings (Asseman
et al., 1999; Zhang et al., 2004). However, our data indicate
that IL-10/ Tregs are not only defective in IL-10 production
but also do not produce adenosine in response to ATP. Thus,
IL-10/ Tregs may not be the right tool to specifically
determine the effects of IL-10 during Treg-mediated immune
suppression. Instead the ATP/adenosine turnover by Tregs has
to be considered too.
ATP acts as a ‘‘danger’’ signal that is also referred to as
‘‘damage-associated molecular pattern’’ (Di Virgilio, 2007).
ATP is a molecule to signal cell death and destruction as it is
present in high concentrations (1mM) in almost all cells, but
its extracellular concentration is kept at very low levels
(below 20nM). Therefore, a passive release of small amounts
of ATP in response to cell injury is easy to detect by
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Figure 3. ATP-mediated activation of wt Tregs is dependent on P2X7. (a) Wt Tregs were stimulated with 200 mM ATP and KN-62 was added. Tregs were
analyzed by flow cytometry after 24 hours in culture. Expression of CD69 and CD44 on only ATP-stimulated Tregs equates 100%. Data show mean±SD of five
independent experiments (*Po0.01). (b) Intracellular calcium mobilization in differently treated wt Tregs. The fluorescence intensity corresponds to the amount
of free intracellular calcium after 1 hour. Bar¼100 mm. (c) CD4þCD25 T cells and Tregs were stimulated separately for 24 hours. Cells were washed and
CD4þCD25 T cells were co-cultured with differently pretreated wt Tregs in the stated ratios. Data show the mean proliferation of CD4þCD25 T cells±SD of
three independent experiments (*Po0.001). ATP, adenosine triphosphate; PMA, phorbol 12-myristate 13-acetate; Treg, regulatory T cell; wt, wild type.
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leukocytes and may serve as an activating trigger for
proinflammatory cells (Di Virgilio et al., 2009b). ATP signals
predominantly through the purinergic P2X7 receptor (Lister
et al., 2007), which is expressed primarily by cells of
hematopoietic origin. Our data showing that blockage of
the P2X7 receptor by antibodies results in abrogated
suppression, corroborate this notion and indicate that Tregs
use the P2X7 receptor to sense ATP in the environment.
The importance of this ATP-mediated activation for in vivo
function of Tregs can be deducted from experiments
investigating the role of Tregs in CHS responses. Here, ATP
is produced at the site of antigen challenge, i.e., skin and
blood vessels, which then causes activation and adenosine
production of local Tregs. After blockage of P2X7 receptors
on the surface of Tregs, the suppressive action is abrogated
in vivo. This indicates that ATP-induced activation of Tregs is
an important means by which inflammatory reactions, such
as the CHS response, trigger the suppressive function of Tregs
(Ring et al., 2010).
The further downstream signaling of P2X7 receptors in
lymphocytes relies on pore formation and induction of
calcium influx into cells (Corriden and Insel, 2010), but the
detailed mechanisms as to how the signaling of P2X7 receptors
is regulated in leukocytes are not completely understood. For
example, pore size, which determines what ions can travel
across the cell membrane, is variable and seems to be
dependent on ATP concentration (Chused et al., 1996;
Virginio et al., 1999). That is, low concentrations of ATP
induce Naþ , Ca2þ , and Kþ fluxes, whereas high concentra-
tions lead to sustained pore opening and increasing diameter,
allowing molecules of up to 450Da to travel. Moreover, even
the downstream events following P2X7 receptor engagement
seem to differ, depending on the strength of the signal.
For example, prolonged opening mediates proinflammatory
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Figure 4. IL-10/ Tregs are impaired in calcium-mediated intracellular signaling. Expressions of the (a) purinergic receptor P2X7 and the (b) ectonucleotidases
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ATP, adenosine triphosphate; PMA, phorbol 12-myristate 13-acetate; Treg, regulatory T cell; wt, wild type.
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cytokine release and cell death, whereas small amounts of ATP
trigger cell proliferation and release of anti-inflammatory
mediators (Adinolfi et al., 2005). Nevertheless, we tested
ATP over a broad range of concentrations, but IL-10/ Tregs
failed to display elevated calcium levels, produced only low
amounts of adenosine, and did not upregulate CD69 in
response to ATP. In this sequence of events, the increase in
intracellular calcium is the first step after engagement of P2X7
receptors and it subsequently acts as a second messenger to
induce cell-activating signals. Thus, as P2X7 receptors do not
affect the intracellular calcium levels in IL-10/ Tregs in the
first place, signaling events, which are normally induced by
elevated intracellular calcium in wt Tregs, are not triggered in
IL-10/ Tregs and cells remain inactive. However, as calcium
and other ions, which may be able to cross ATP-induced
pores, have pleiotropic effects in several signal transduction
pathways in cells, the detailed mechanisms as to how the P2X7
receptor is impaired in signal transduction in IL-10/ Tregs
have to be determined in future investigations. The cross-talk
between P2X7 receptor signaling and cytokine release has
been investigated inasmuch as ATP receptor engagement
increased the production of IL-10, tumor necrosis factor-a,
IL-1b, and IL-6 (Solini et al., 1999; Hide et al., 2000; Swennen
et al., 2005; Ferrari et al., 2006; Seo et al., 2008). In particular
for IL-10, an autocrine loop has been proposed in microglia
cells. Here, stimulation of cells with lipopolysaccharide
induces ATP release that act back on cells by inducing IL-10
release (Seo et al., 2008). However, we tested the opposite
pathway by adding recombinant IL-10 to IL-10/ Tregs and
subsequently analyzing for activation, for adenosine produc-
tion, and for P2X7 receptor expression of cells. Here, we did
not record any changes in wt or 10/ Tregs, thus, indicating
that ATP-induced effects on Tregs do not seem to be
modulated by exogenous IL-10, and a feedback loop in which
IL-10 and adenosine regulate each other is not responsible for
the observed effects. However, one can only speculate on the
underlying mechanisms. For example, IL-10 may be required
intracellularly; therefore, exogenous IL-10 is ineffective. In
addition, prolonged exposure of Tregs to autocrine produced
IL-10, or additional so far unidentified soluble factors
produced by bystander cells in vivo, may be necessary to
maintain the responsiveness of Tregs to ATP. Despite the fact
that the underlying mechanism remains to be elucidated, our
data show that IL-10/ Tregs do not become activated by ATP
and do not produce immunosuppressive adenosine in sizable
amounts. Thus, the usage of IL-10/ Tregs to pinpoint the
effects of IL-10 in Treg-mediated suppression needs to be
revisited and effects mediated by adenosine have to be taken
into account in the future.
MATERIALS AND METHODS
Mice
Bl6 mice were purchased from Charles River (Sulzfeld, Germany)
and housed at the central animal facility of the University of
Heidelberg. IL-10/ mice on a C57BL/6 background were obtained
from Jackson Laboratories (Bar Harbor, ME). All experiments were
approved by the state of Baden-Wu¨rttemberg and performed in
accordance with the governmental guidelines.
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Figure 5. Extracellular IL-10 does not compensate for the lack of intracellular IL-10 in IL-10/ mice. Wt Tregs and IL-10/ Tregs were stimulated with ATP
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Analysis of the activation status of injected naive Tregs during
CHS reaction
CD4þCD25þ Tregs were isolated from lymph node and spleen cells
using the CD4þCD25þ Regulatory T Cell Isolation Kit (Miltenyi
Biotec, Bergisch Gladbach, Germany) according to the manufacturer’s
protocol. Tregs were labeled with the fluorescent dye PKH26, and
3 106 PKH26-labeled Tregs were injected intravenously into
2,4,6-trinitrochlorobenzene sensitized mice, followed by 2,4,6-trinitro-
chlorobenzene challenge on the ear. Mice were killed 24hours after
Treg injection, and activation statuses of Tregs were analyzed in the cell
suspension of different organs by flow cytometry.
Determination of the activation status and detection of
adenosine
Overall, 2 105 Tregs were cultured in 200ml per well in 96-well round-
bottom plates and stimulated either with anti-CD3 and anti-CD28
(BD Biosciences, Heidelberg, Germany, 0.5mgml1 each) or with
different amounts of ATP (Sigma-Aldrich, Taufkirchen, Germany)
(75, 125, 200mM). IL-10 (BD Biosciences; 10 or 25ngml1) or anti-IL-
10 (BD Biosciences, clone JES5-2A5; 1 or 10mgml1) was added in
some experiments. Activation statuses of cells were analyzed after
24hours by flow cytometry. The supernatants were analyzed for
adenosine using a high-pressure liquid chromatograph. A volume of
20ml aliquots of the samples was measured with a 0–7% acetonitrile/
H2O gradient mobile phase and absorption was measured at 260nm.
Proliferation assay
CD4þ T cells and Tregs were stimulated separately with either anti-
CD3 and anti-CD28 (0.5 mgml1 each) or ATP (125 mM) for 24 hours.
Cells were washed thoroughly and co-cultured in different ratios
without further stimulation. After 24 hours, 0.5 mCiml1 [3H]-
thymidine (Amersham, Freiburg, Germany) was added for 18 hours,
cells were harvested, and thymidine incorporation was determined
using a Perkin-Elmer scintillation counter (Perkin-Elmer, Rodgau,
Germany).
Flow chamber
The murine EC line (bEND.3; ATCC, Wesel, Germany) was cultured
on cover slips and stimulated with tumor necrosis factor-a
(1mgml1) or tumor necrosis factor-a together with Tregs (5 105
per ml). After 24hours, the cover slips were placed in a heated flow
chamber (Chromaphor, Bottrop, Germany) and superfused with
fluorescent dye-labeled CD4þ T cells. The number of rolling and
adherent cells per visible field was determined using video microscopy.
Detection of intracellular calcium mobilization
Intracellular calcium mobilization was determined using the
FluoForte Calcium Assay Kit (Enzo Life Sciences, Lo¨rrach, Germany).
Tregs were resuspended in dye-loading solution, and 1.75 105
cells per 100ml per well were cultured in a 96-well flat-bottom plate
with or without KN-62. The plate was centrifuged with brake off and
incubated for 1 hour at room temperature. PMA/ionomycin or ATP
(200mM) was added to the wells and the increase in fluorescence was
monitored using a fluorescence microscope (excitation¼ 490 nm/
emission¼ 525nm). Pictures were taken every 10minutes for 1 hour.
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